Leif Gerrit Keferstein

Dr. Leif Gerrit Keferstein


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
LKLeif Gerrit Keferstein
Leif Gerrit Keferstein
The purpose of this paper is to evaluate the possible application of a therapeutic carnivore diet regimen in the treatment of chronic inflammatory bowel disease (IBD). Based on current research and anecdotal reports, we hypothesized that the diet might potentially exhibit both anti-inflammatory and microbiome-modulating properties salutary to the IBD patient population. Our hypothesis demands comprehensive clinical validation. Therefore, in this paper, we review theories on ketogenic and carnivore diets, discussing their immunomodulatory effects and propose an experimental study to test the feasibility, safety, and clinical efficacy of the carnivore diet for IBD treatment.

21 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
LKLeif Gerrit Keferstein
Leif Gerrit Keferstein
JBJohannes Breidenbach
Johannes Breidenbach
Background: A healthy 31-year-old male, with a history of veganism followed by a carnivorous diet, sought to adopt a Maasai-inspired diet consisting exclusively of cow’s blood and milk for 30 days. The subject, a physically active forest worker, aimed to address health issues experienced during his vegan period, which included depression, being underweight, tooth decay, and loss of libido. Methods: The subject collected (from the butcher) and prepared 2 liters of cow’s blood weekly, ensuring it remained non-coagulant through stirring, and refrigerated for up to 7 days. Forty liters of raw milk were procured, from which cream was separated and consumed to minimize casein intake. Biochemical parameters were monitored, including CRP levels, lipid profile, liver enzymes, renal function, electrolytes, and others. Results: Over the 30-day period, the subject’s blood and cream consumption varied, with an intake of cow’s blood on 21 days (30mL to 400mL) and cow’s cream on all days (200mL to 2100mL). Raw milk was introduced on Day 7 and consumed on 24 days (100mL to 1750mL). Notable biochemical changes included an increase in blood glucose (+5.4%), LDL/HDL ratio improvement (+9.6%), free testosterone (+24.9%), and a significant decrease in total bilirubin (-32.3%) and MDA-LDL (-67.9%). Other parameters showed mixed results, with decreases in various liver enzymes and cholesterol levels, and increases in creatinine clearance and certain minerals. Conclusion: The exclusive consumption of cow’s blood and milk resulted in numerous changes in biochemical markers, some of which may be beneficial, while others require cautious interpretation. The diet led to significant alterations in lipid metabolism, liver function, renal function, and mineral status, warranting further study on the long-term implications of such dietary practices.

22 September 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
JSJoshua Sauren
Joshua Sauren
DHDavid Hoehfeld
David Hoehfeld
LKLeif Gerrit Keferstein
Leif Gerrit Keferstein
Efficacy of mitochondrial-based interventions in the management of clinical depression- A systematic review

26 September 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
JSJoshua Sauren
Joshua Sauren
DHDavid Höhfeld
David Höhfeld
LKLeif Gerrit Keferstein
Leif Gerrit Keferstein
Background: Crohn's disease (CD) is a chronic inflammatory bowel disorder with limited treatment options. Mitochondrial dysfunction has been implicated in CD pathogenesis, and mitochondrial-based interventions have emerged as a potential therapeutic avenue. This systematic review aimed to assess the efficacy of mitochondrial-based interventions in the management of CD. Methods: A systematic search of multiple databases was conducted to identify relevant studies in accordance with the PRISMA protocol. Inclusion criteria encompassed studies investigating mitochondrial-targeted interventions in CD patients. Methodological quality and risk of bias assessments were performed. Data synthesis involved both quantitative meta-analysis and qualitative narrative synthesis. Results: A total of 23 studies were included in this review, comprising randomized controlled trials, observational studies, and case reports. Mitochondrial-based interventions encompassed nutraceuticals, probiotics, exercise, and dietary modifications. However, the overall quality of evidence was moderate, primarily due to methodological limitations in some studies. Conclusion: This systematic review suggests that mitochondrial-based interventions hold promise as adjunctive therapies for CD management. They appear to contribute to clinical remission and amelioration of disease activity. Nevertheless, the moderate quality of evidence underscores the need for further well-designed clinical trials to substantiate these findings and delineate optimal intervention strategies.

17 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
LKLeif Gerrit Keferstein
Leif Gerrit Keferstein
CWChristoph Wesseling
Christoph Wesseling
DHDavid Höhfeld
David Höhfeld
JSJoshua Sauren
Joshua Sauren
DWDorin Walde
Dorin Walde
JSJannis Stenzel
Jannis Stenzel
Chronic non-communicable diseases (NCDs) represent the greatest medical challenge of the 21st 2 century. Eighty percent of the etiology of chronic diseases is non-genetic. Chronic diseases are not 3 monogenetic, static defects, but rather the expression of disturbed regulatory processes within the 4 body’s biological memory systems — metabolic, immunological, and neuronal. This framework 5 understands health as a dynamic state of functional energy allocation and adaptive plasticity, which 6 can be regulated through epigenetic, mitochondrial, and neuroendocrine mechanisms. It connects 7 modern systems biology with the principles of behavioral and neuropsychology and proposes that 8 self-efficacy, coherence, and voluntariness function not merely as ethical ideals but as biologically 9 supportive conditions for healing. Emerging evidence suggests that targeted habitual interventions 10 can induce profound changes in gene expression, mitohormesis, and immune regulation, potentially 11 making epigenetically fixed disease patterns partially reversible. By integrating molecular biology, 12 behavioral science, and mentor-based formats, this system aims to bridge the gap between biomedical 13 knowledge and effective patient care. This paper proposes an integrative theoretical framework: 14 regeneration is understood not as a passive process but as an active learning process of the organism. 15 Healing arises when biological, psychological, and social systems are brought into coherent resonance. 16 In this sense, this proposed system forms the bridge between molecular biology, lifestyle research, and 17 human experience — with the goal of not merely measuring health, but consciously cultivating it.

10 October 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
LKLeif Gerrit Keferstein
Leif Gerrit Keferstein
Background: This study aimed to compile and analyze an assortment of research findings concerning potential therapeutic strategies for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). The understanding of the multifaceted nature of ME/CFS and the need for varied and personalized therapeutic approaches were central to this investigation.Methods: A comprehensive review and analysis of various studies conducted on ME/CFS was undertaken. These studies covered a wide array of interventions, including pharmacological treatments, nutritional supplements, dietary changes, physical therapies, and lifestyle modifications. The analysis pertained to the effectiveness of these interventions, potential physiological and biochemical markers, and the response of ME/CFS patients to different treatment strategies.Results: The 22 selected papers investigated demonstrated varied responses to the multitude of interventions. While some interventions showed significant improvement in fatigue and biochemical parameters, others found no significant differences between the treated and control groups. Potential physiological and biochemical markers for ME/CFS, such as impaired T cell metabolism, reduced flow-mediated dilation, and decreased work rate at the ventilatory threshold, were highlighted.Conclusion: The findings underscored the complexity of ME/CFS and the need for personalized treatment strategies. Despite mixed results and several limitations, these studies collectively contributed to understanding ME/CFS's complex pathophysiology and treatment, laying the groundwork for future research towards more effective therapeutic strategies for this debilitating disease.